2010
DOI: 10.1016/j.peptides.2010.05.011
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of the epinecidin-1 peptide as an active ingredient in cleaning solutions against pathogens

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
15
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 21 publications
(16 citation statements)
references
References 30 publications
1
15
0
Order By: Relevance
“…Epinecidin-1 showed to be a potential candidate for topical application that can prevent vaginal or skin infections due to the synergistic effect that possess with commercial cleaning solutions, where such effect was not affected by low pH or after being stored at room temperature and at 4 °C for up to 14 days [211]. The synergistic effect of pleurocidin and several antibiotics [212], bacteroricin [213] and histone-derived [214] has also been shown [212,213].…”
Section: Therapeuticsmentioning
confidence: 99%
“…Epinecidin-1 showed to be a potential candidate for topical application that can prevent vaginal or skin infections due to the synergistic effect that possess with commercial cleaning solutions, where such effect was not affected by low pH or after being stored at room temperature and at 4 °C for up to 14 days [211]. The synergistic effect of pleurocidin and several antibiotics [212], bacteroricin [213] and histone-derived [214] has also been shown [212,213].…”
Section: Therapeuticsmentioning
confidence: 99%
“…The synthesised peptide was dissolved in 0.1 M sterile PBS (pH 7.3), and its antimicrobial activities were monitored on the basis of minimum inhibitory concentrations (MICs). The inhibitory property of XLAsp-P2 on chloramphenicol-resistant Staphylococcus aureus RN4200, S. aureus ATCC29213, Staphylococcus sciuri ATCC29062, Rothia nasimurium ATCC19426, Aerococcus viridans ATCC700406, S. aureus ATCC25922, Escherichia coli BL21, Klebsiella pneumoniae ATCC23356 and Aeruginosus bacillus ATCC47085 was examined in accordance with standard protocols and clinical and laboratory standard institute guidelines [14], and with broth dilution method [15]. The microorganisms were grown for 18 h at 37°C on their respective media: E. coli and S. aureus in Mueller-Hinton (MH) broth, Candida albicans in YPD diluted to a cell final concentration of 10 5 colony-forming units (CFU) per millilitre.…”
Section: Antimicrobial Activity Assay and Bactericidal Kinetics Assaymentioning
confidence: 99%
“…This strain is resistant to ampicillin, methicillin, oxacillin, and ciprofloxacin. The culture and quantification were performed as previously described [21, 22]. …”
Section: Methodsmentioning
confidence: 99%